Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: memo - Magazine of European Medical Oncology 3/2020

25.05.2020 | original report

Comparison of outcomes of two non-BCNU-containing conditioning regimens used in autologous stem cell transplantation for relapsed/refractory lymphoma

verfasst von: Amro Mohamed Sedky El-Ghammaz, Maha El-Zimaity, Afaf Abdel-Aziz Abdel-Ghaffar

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Background

A comparison was performed of outcomes of two non-BCNU-containing conditioning regimens used in autologous stem cell transplantation (ASCT) for lymphoma due to the lack of superiority of any regimen over others in the setting of the global BCNU shortage.

Methods

CCVP-16 and LEAM conditioning regimens were compared in 55 relapsed/refractory lymphoma patients regarding engraftment timing, hospitalization duration, toxicity profile, disease progression and survival.

Results

There was insignificant difference between the two regimens regarding engraftment timings, hospitalization durations and toxicities. However, LEAM was associated with a lower post-ASCT disease progression rate than CCVP-16 in the whole cohort and in the Hodgkin lymphoma subgroup. Overall survival did not differ between the two regimens in the whole cohort and in Hodgkin lymphoma and diffuse large B cell lymphoma subgroups. In contrast, progression free survival was superior with LEAM in comparison to CCVP-16 in the whole cohort and in the Hodgkin lymphoma subgroup.

Conclusion

LEAM is more effective than CCVP-16 in ASCT for lymphoma, especially Hodgkin lymphoma, and has a comparable toxicity profile.
Literatur
1.
Zurück zum Zitat Filmont JE, Gisselbrecht C, Cuenca X, et al. The impact of pre- and post-transplantation positron emission tomography using 18-fluorodeoxyglucose on poor-prognosis lymphoma patients undergoing autologous stem cell transplantation. Cancer. 2007;110:1361–9. CrossRef Filmont JE, Gisselbrecht C, Cuenca X, et al. The impact of pre- and post-transplantation positron emission tomography using 18-fluorodeoxyglucose on poor-prognosis lymphoma patients undergoing autologous stem cell transplantation. Cancer. 2007;110:1361–9. CrossRef
2.
Zurück zum Zitat Armitage JO. Treatment of non-Hodgkin’s lymphoma. N Engl J Med. 1993;328:1023–30. CrossRef Armitage JO. Treatment of non-Hodgkin’s lymphoma. N Engl J Med. 1993;328:1023–30. CrossRef
3.
Zurück zum Zitat Colpo A, Hochberg E, Chen YB. Current status of autologous stem cell transplantation in relapsed and refractory Hodgkin’s lymphoma. Oncologist. 2012;17:80–90. CrossRef Colpo A, Hochberg E, Chen YB. Current status of autologous stem cell transplantation in relapsed and refractory Hodgkin’s lymphoma. Oncologist. 2012;17:80–90. CrossRef
4.
Zurück zum Zitat Nademanee A. Transplantation for non-Hodgkin lymphoma. Expert Rev Hematol. 2009;2:425–42. CrossRef Nademanee A. Transplantation for non-Hodgkin lymphoma. Expert Rev Hematol. 2009;2:425–42. CrossRef
5.
Zurück zum Zitat Rezvani AR, Storb RF. Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation. J Autoimmun. 2008;30(3):172–9. CrossRef Rezvani AR, Storb RF. Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation. J Autoimmun. 2008;30(3):172–9. CrossRef
6.
Zurück zum Zitat Mounier N, Gisselbrecht C. Conditioning regimens before transplantation in patients with aggressive non-Hodgkin’s lymphoma. Ann Oncol. 1998;9(Suppl. I):S15–S21. CrossRef Mounier N, Gisselbrecht C. Conditioning regimens before transplantation in patients with aggressive non-Hodgkin’s lymphoma. Ann Oncol. 1998;9(Suppl. I):S15–S21. CrossRef
7.
Zurück zum Zitat Sharma A, Kayal S, Iqbal S, Malik PS, Raina V. Comparison of BEAM vs. LEAM regimen in autologous transplant for lymphoma at AIIMS. SpringerPlus. 2013;2:489. CrossRef Sharma A, Kayal S, Iqbal S, Malik PS, Raina V. Comparison of BEAM vs. LEAM regimen in autologous transplant for lymphoma at AIIMS. SpringerPlus. 2013;2:489. CrossRef
8.
Zurück zum Zitat Stuart MJ, Chao NS, Horning SJ, et al. Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin’s disease. Biol Blood Marrow Transplant. 2001;7:552–60. CrossRef Stuart MJ, Chao NS, Horning SJ, et al. Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin’s disease. Biol Blood Marrow Transplant. 2001;7:552–60. CrossRef
9.
Zurück zum Zitat Fernandez HF, Escalon MP, Pereira D, Lazarus HM. Autotransplant conditioning regimens for aggressive lymphoma: are we on the right road? Bone Marrow Transplant. 2007;40:505–13. CrossRef Fernandez HF, Escalon MP, Pereira D, Lazarus HM. Autotransplant conditioning regimens for aggressive lymphoma: are we on the right road? Bone Marrow Transplant. 2007;40:505–13. CrossRef
10.
Zurück zum Zitat Sorror ML, Maris MB, Storb R, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106:2912–9. CrossRef Sorror ML, Maris MB, Storb R, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106:2912–9. CrossRef
11.
Zurück zum Zitat Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059–67. CrossRef Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059–67. CrossRef
12.
Zurück zum Zitat Mabed M, Shamaa S. High-dose chemotherapy plus non-cryopreserved autologous peripheral blood stem cell transplantation rescue for patients with refractory or relapsed Hodgkin disease. Biol Blood Marrow Transplant. 2006;12:942–8. CrossRef Mabed M, Shamaa S. High-dose chemotherapy plus non-cryopreserved autologous peripheral blood stem cell transplantation rescue for patients with refractory or relapsed Hodgkin disease. Biol Blood Marrow Transplant. 2006;12:942–8. CrossRef
13.
Zurück zum Zitat Ramzi M, Mohamadian M, Vojdani R, et al. Autologous non-cryopreserved hematopoietic stem cell transplant with CEAM as a modified conditioning regimen in patients with Hodgkin lymphoma: a single-center experience with a new protocol. Exp Clin Transplant. 2012;2:163–7. CrossRef Ramzi M, Mohamadian M, Vojdani R, et al. Autologous non-cryopreserved hematopoietic stem cell transplant with CEAM as a modified conditioning regimen in patients with Hodgkin lymphoma: a single-center experience with a new protocol. Exp Clin Transplant. 2012;2:163–7. CrossRef
15.
Zurück zum Zitat Salar A, Sierra J, Gandarillas M, et al. Autologous stem cell transplantation for clinically aggressive non-Hodgkin’s lymphoma: the role of preparative regimens. Bone Marrow Transplant. 2001;27(4):405–12. CrossRef Salar A, Sierra J, Gandarillas M, et al. Autologous stem cell transplantation for clinically aggressive non-Hodgkin’s lymphoma: the role of preparative regimens. Bone Marrow Transplant. 2001;27(4):405–12. CrossRef
16.
Zurück zum Zitat Majhail NS, Ness KK, Burns LJ, et al. Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study. Biol Blood Marrow Transplant. 2007;13:1153–9. CrossRef Majhail NS, Ness KK, Burns LJ, et al. Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study. Biol Blood Marrow Transplant. 2007;13:1153–9. CrossRef
17.
Zurück zum Zitat Gutierrez-Delgado F, Maloney DG, Press OW, et al. Autologous stem cell transplantation for non-Hodgkin’s lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens. Bone Marrow Transplant. 2001;28:455–61. CrossRef Gutierrez-Delgado F, Maloney DG, Press OW, et al. Autologous stem cell transplantation for non-Hodgkin’s lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens. Bone Marrow Transplant. 2001;28:455–61. CrossRef
18.
Zurück zum Zitat Caballero MD, Rubio V, Rifon J, et al. BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors. Bone Marrow Transplant. 1997;20:451–8. CrossRef Caballero MD, Rubio V, Rifon J, et al. BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors. Bone Marrow Transplant. 1997;20:451–8. CrossRef
19.
Zurück zum Zitat Alessandrino EP, Bernasconi P, Colombo A, et al. Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies. Bone Marrow Transplant. 2000;25:309–13. CrossRef Alessandrino EP, Bernasconi P, Colombo A, et al. Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies. Bone Marrow Transplant. 2000;25:309–13. CrossRef
20.
Zurück zum Zitat Cordonnier C, Vernant JP, Mital P, Lange F, Bernaudin JF, Rochant H. Pulmonary fibrosis subsequent to high doses of CCNU for chronic myeloid leukemia. Cancer. 1983;51:1814–8. CrossRef Cordonnier C, Vernant JP, Mital P, Lange F, Bernaudin JF, Rochant H. Pulmonary fibrosis subsequent to high doses of CCNU for chronic myeloid leukemia. Cancer. 1983;51:1814–8. CrossRef
21.
Zurück zum Zitat Charley C, Babic A, Bargalló Arraut I, Ferrero I. JACIE and quality management in HSCT: implications for nursing. In: Kenyon M, Babic A, editors. The European blood and marrow transplantation textbook for nurses. Cham: Springer; 2018. pp. 1–22. Charley C, Babic A, Bargalló Arraut I, Ferrero I. JACIE and quality management in HSCT: implications for nursing. In: Kenyon M, Babic A, editors. The European blood and marrow transplantation textbook for nurses. Cham: Springer; 2018. pp. 1–22.
22.
Zurück zum Zitat Chen YB, Lane AA, Logan B, et al. Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2015;21(6):1046–53. CrossRef Chen YB, Lane AA, Logan B, et al. Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2015;21(6):1046–53. CrossRef
23.
Zurück zum Zitat Gupta A, Gokarn A, Rajamanickam D, et al. Lomustine, cytarabine, cyclophosphamide, etoposide—an effective conditioning regimen in autologous hematopoietic stem cell transplant for primary refractory or relapsed lymphoma: Analysis of toxicity, long-term outcome, and prognostic factors. J Cancer Res Ther. 2018;14(5):926–33. CrossRef Gupta A, Gokarn A, Rajamanickam D, et al. Lomustine, cytarabine, cyclophosphamide, etoposide—an effective conditioning regimen in autologous hematopoietic stem cell transplant for primary refractory or relapsed lymphoma: Analysis of toxicity, long-term outcome, and prognostic factors. J Cancer Res Ther. 2018;14(5):926–33. CrossRef
24.
Zurück zum Zitat Zhang J, Grubor V, Love CL, et al. Genetic heterogeneity of diffuse large B‑cell lymphoma. Proc Natl Acad Sci U S A. 2013;110(4):1398–403. CrossRef Zhang J, Grubor V, Love CL, et al. Genetic heterogeneity of diffuse large B‑cell lymphoma. Proc Natl Acad Sci U S A. 2013;110(4):1398–403. CrossRef
25.
Zurück zum Zitat Shu Z, Heimfeld S, Gao D. Hematopoietic stem cell transplantation with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal prior to infusion. Bone Marrow Transplant. 2014;49:469–76. CrossRef Shu Z, Heimfeld S, Gao D. Hematopoietic stem cell transplantation with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal prior to infusion. Bone Marrow Transplant. 2014;49:469–76. CrossRef
Metadaten
Titel
Comparison of outcomes of two non-BCNU-containing conditioning regimens used in autologous stem cell transplantation for relapsed/refractory lymphoma
verfasst von
Amro Mohamed Sedky El-Ghammaz
Maha El-Zimaity
Afaf Abdel-Aziz Abdel-Ghaffar
Publikationsdatum
25.05.2020
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 3/2020
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-020-00621-0

Weitere Artikel der Ausgabe 3/2020

memo - Magazine of European Medical Oncology 3/2020 Zur Ausgabe